Although I am not a neurologist, I think a lot about the #variants of #PrimaryProgressiveAphasia. I wrote a #memoir about my father's #early-onset #Alzheimer's with #neurologist, #Dr.BruceMiller of #UCSF's #MemoryAndAgingCenter. It explains where in the #brain the initial assault happens and helps us understand why people can't find the right words and/or garble them and/or repeat them. After many years, I learned that my father had the #logopenic variant.
This will be my ongoing🧵on exercise b/c I need to organize dammit as can’t find anything
In 2020 recall reading a tiny blip of an article about exercise post Covid & WILL eventually hunt it down
Swore it was WP but searching “Washington post, Covid exercise” is getting me mostly pro exercise articles🤦🏻♀️ such as this gem from my favorite 🙄🙄Covid resource Leana Wen /s
Written in 2023 but 2024, they are FINALLY pointing out obvious truth
how about talking about how it damages #tcells instead of dated info from some immunology book back from when you were in Med school🙄
it👏🏼is👏🏼called👏🏼a👏🏼novel👏🏼virus👏🏼… for a reason!!!
also reasoning of not vaccinating #xbb for those under 65 to lessen burden on #nhs … 😶…😶😶😶😶😶🤯
Do these people hear themselves?🤦🏻♀️
I’m not dumb, ditzy on occasion but I get things eventually, however I read & see things constantly that are making me second guess myself; maddening
Prof Openshaw said: "The #viruses circulating now are pretty distant immunologically from the original #virus which was used to make the early #vaccines, or which last infected them.
"A lot of people have very little immunity to the #Omicron viruses and their #variants ."
WTF #misinformation is this?!?!
THERE IS NO NOR HAS THERE EVER BEEN DURABLE IMMUNITY TO A VIRUS THAT HAS MUTATED MORE IN 3 YEARS THAN FLU IN 15+++++ YEARS even if you were just infected
You have time for a 3-minute 🧵 on #COVID19 & why you should be cautious, right?
If you get infected this weekend, you'll almost certainly be sick for the holidays. That either means staying home or risking spreading unnecessary viruses to your friends and loved ones.
COVID in wastewater in the Midwest is at its highest point in two years. In the Northeast, COVID is at its highest since last holidays. https://biobot.io/data/
Ooh pretty colors🙄
No but really, I find this chart helpful is seeing the classification of different #variants & why clearly there’s no durable immunity outside those strains
@EnemyInAState has a better explainer but if you know, you know
Antigenicity and infectivity characterization of #SARSCoV2#BA286
> it appears that BA.2.86 has traded its infectivity for higher immune evasion during long-term host-viral evolution
> we found that BA.2.86 can induce significant antibody evasion of XBB-stimulated plasma
> the data ... suggest BA.2.86 is highly immune evasive and could have advantages over currently circulating variants regarding the ability to resist XBB-induced humoral immunity.
Third week of Hyperion-2 XBB.1.9.2/EG wave. Last week's CDC Nowcast estimated third of samples were Eris EG.5.1 descendants—with Eris scion HV.1 at ¼ of samples.
For 3-week GISAID sequences, Eris EG.5.1 fam now all but half share. Hyperion XBB.1.9.1 fam below ⅒. Arcturus XBB.1.16 fam now below ⅕.
A new study has found that people differ in how vulnerable they are to different mutations in emerging variants of #SARS-CoV-2. This is because the variant of SARS-CoV-2 a person was first exposed to determines how well their #immune system responds to different parts of the #virus, and how protected they are against other #variants. #Virology#Covid#sflorg https://www.sflorg.com/2023/10/vi10062301.html
Some are describing the #Novavax#vaccine having the ability to target the parts of the #virus that stay the same. This is a little misleading since Novavax + #adjuvant and your immune system have no idea what parts of the #spike are going to change in new #variants. 🧵 1/
Twenty-second week of post-Kraken soup, Hyperion-2 XBB.1.9.2/EG approaches four tenths of three-week GISAID sequences; Hyperion 1.9.1/FL down below one in seven.
Arcturus XBB.1.16 family down to below one in four; Kraken XBB.1.5 fam holds below one in ten; Acrux 2.3 fam now below one in thirteen.
Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses.